-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KO-2806 in Head And Neck Squamous Cell Carcinoma (HNSC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KO-2806 in Head And Neck Squamous Cell Carcinoma (HNSC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KO-2806 in Head And Neck Squamous Cell...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KO-2806 in Head And Neck Cancer Squamous Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KO-2806 in Head And Neck Cancer Squamous Cell Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KO-2806 in Head And Neck Cancer Squamous...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dinutuximab Beta in Leiomyosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dinutuximab Beta in Leiomyosarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Dinutuximab Beta in Leiomyosarcoma Drug Details:Dinutuximab beta (APN-311, Isqette, Qarziba) is a chimeric...
-
Product Insights
Kerzner Intl Resorts – Ko Olina Ocean-Themed Resort – Hawaii
Equip yourself with the essential tools needed to make informed and profitable decisions with our Kerzner Intl Resorts - Ko Olina Ocean-Themed Resort - Hawaii report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
HA Hong Kong – Ko Shan Road Residential Flat Development – Kowloon City
Equip yourself with the essential tools needed to make informed and profitable decisions with our HA Hong Kong - Ko Shan Road Residential Flat Development - Kowloon City report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
Resort Group/ Westbank Corp – Four Seasons Resort Oahu at Ko Olina – Hawaii
Equip yourself with the essential tools needed to make informed and profitable decisions with our Resort Group/ Westbank Corp - Four Seasons Resort Oahu at Ko Olina - Hawaii report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Product Insights
Dept of Rural Roads Thailand – Hua Hin to Ko Lanta Noi Suspension Bridge – Krabi
Equip yourself with the essential tools needed to make informed and profitable decisions with our Dept of Rural Roads Thailand - Hua Hin to Ko Lanta Noi Suspension Bridge - Krabi report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report?...
-
Product Insights
ASD Hong Kong – Ko Chiu Road General Outpatient Clinic and Child Assessment Centre – Kwun Tong
Equip yourself with the essential tools needed to make informed and profitable decisions with our ASD Hong Kong - Ko Chiu Road General Outpatient Clinic and Child Assessment Centre - Kwun Tong report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our...
-
Company Profile
Kura Oncology Inc – Company Profile
Kura Oncology Inc (Kura Oncology) is a biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company’s lead drug candidate Tipifarnib, an inhibitor of farnesyl transferase, an oral investigational drug candidate intended for the treatment of various types of cancer including HRAS mutant head and neck cancer, peripheral T-cell lymphomas, myelodysplastic syndromes and chronic myelomonocytic leukemia. Its other candidates include KO-947, an investigational drug candidate for mitogen-activated protein kinase pathway tumors and...
Add to Basket -
Product Insights
Kosice City – Košice Football Stadium – Kosicky
Equip yourself with the essential tools needed to make informed and profitable decisions with our Kosice City - Košice Football Stadium - Kosicky report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...